| Dr Keith Gerard Leblanc Jr, MD | |
|
1615 Metairie Rd, Suite 101, Metairie, LA 70005-3974 | |
| (504) 644-4226 | |
| (504) 208-1135 |
| Full Name | Dr Keith Gerard Leblanc Jr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 16 Years |
| Location | 1615 Metairie Rd, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972765493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD31526 (Alabama) | Secondary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | MD.206061 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana State University School Of Medicine In New Orleans Faculty G | 0244136448 | 380 |
| The Skin Surgery Centre Llc | 5294969291 | 4 |
| The Skin Surgery Centre Llc | 5294969291 | 4 |
News Archive
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.
Latest figures from the U.S. Centers for Disease Control and Prevention (CDC), say since 1st August 2006, 628 people in 47 states have been infected with salmonellosis after eating peanut butter contaminated with the Tennessee strain of Salmonella.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
› Verified 6 days ago
| Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.
Latest figures from the U.S. Centers for Disease Control and Prevention (CDC), say since 1st August 2006, 628 people in 47 states have been infected with salmonellosis after eating peanut butter contaminated with the Tennessee strain of Salmonella.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
› Verified 6 days ago
| Entity Name | The Skin Surgery Centre Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730522087 PECOS PAC ID: 5294969291 Enrollment ID: O20131007000330 |
News Archive
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.
Latest figures from the U.S. Centers for Disease Control and Prevention (CDC), say since 1st August 2006, 628 people in 47 states have been infected with salmonellosis after eating peanut butter contaminated with the Tennessee strain of Salmonella.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
› Verified 6 days ago
| Entity Name | Integrated Dermatology Of Ponchatoula Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508234600 PECOS PAC ID: 6103126974 Enrollment ID: O20151130001653 |
News Archive
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.
Latest figures from the U.S. Centers for Disease Control and Prevention (CDC), say since 1st August 2006, 628 people in 47 states have been infected with salmonellosis after eating peanut butter contaminated with the Tennessee strain of Salmonella.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith Gerard Leblanc Jr, MD 1615 Metairie Rd, Suite 101, Metairie, LA 70005-3974 Ph: (504) 644-4226 | Dr Keith Gerard Leblanc Jr, MD 1615 Metairie Rd, Suite 101, Metairie, LA 70005-3974 Ph: (504) 644-4226 |
News Archive
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.
Latest figures from the U.S. Centers for Disease Control and Prevention (CDC), say since 1st August 2006, 628 people in 47 states have been infected with salmonellosis after eating peanut butter contaminated with the Tennessee strain of Salmonella.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
› Verified 6 days ago
Mrs. Diane Loria Rose, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2221 Clearview Pkwy, Suite 101, Metairie, LA 70001 Phone: 504-885-8363 Fax: 504-885-1005 | |
Dr. William Patrick Coleman Iv, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4425 Conlin St, Metairie, LA 70006 Phone: 504-455-3180 | |
Dr. Vanessa Bailyn Voss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1615 Metairie Rd, Metairie, LA 70005 Phone: 504-644-4226 | |
Elizabeth F Bucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1615 Metairie Rd, Suite 101, Metairie, LA 70005 Phone: 504-644-4226 | |
Dr. Rachael Marie Delahoussaye-shields, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3800 Houma Blvd Ste 310, Metairie, LA 70006 Phone: 504-454-2997 Fax: 504-454-2763 | |
Dr. Robert Andrew Koppel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3640 Houma Blvd, Metairie, LA 70006 Phone: 504-454-1885 Fax: 504-454-0925 | |
Dr. Adrian Dobrescu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4401 Veterans Memorial Blvd, Suite 100, Metairie, LA 70006 Phone: 504-899-6652 Fax: 504-899-6653 |